Clinical Trial Update: Honghuaruyi Wan for Endometriosis Dysmenorrhea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Honghuaruyi Wan targeting endometriosis and dysmenorrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Endometriosis

Drugs mentioned

• Honghuaruyi Wan

Snippet

Sponsor: Beijing University of Chinese Medicine | Conditions: Endometriosis, Dysmenorrhea | Phase 4 | Status: UNKNOWN